2026 Autoimmune Neurology Conference | C4 - Neuro-rheumatology
| 01:15 PM - 01:42 PM CDT | Speaker |
Neurological Manifestations of Vasculitis (Central and Peripheral Nervous System)
Jeffrey M. Gelfand, MD, MS, FÂé¶¹´«Ã½Ó³» |
| 01:42 PM - 02:09 PM CDT | Speaker |
Neurological Manifestations of Systemic Lupus Erythematosus (SLE) and Sjögren’s Syndrome
Mayra Montalvo Perero, MD |
| 02:09 PM - 02:36 PM CDT | Speaker |
IgG4 Disease Updates for the Neurologist
Bart Chwalisz, MD |
| 02:36 PM - 02:46 PM CDT | Speaker |
Abstract Presentation #1
|
| 02:46 PM - 02:56 PM CDT | Speaker |
Abstract Presentation #2
|
| Shamik Bhattacharyya, MD, FÂé¶¹´«Ã½Ó³» | Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. The institution of Dr. Bhattacharyya has received research support from TG Therapeutics. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. |
| Melissa A. Wright, MD | Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . |
| Jeffrey M. Gelfand, MD, MS, FÂé¶¹´«Ã½Ó³» | Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. |
| Mayra Montalvo Perero, MD | Dr. Montalvo Perero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG THERAPEUTICS. Dr. Montalvo Perero has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. |
| Eoin P. Flanagan, MBBCh, FÂé¶¹´«Ã½Ó³» | The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. |
| Anastasia Zekeridou, MD, PhD, FÂé¶¹´«Ã½Ó³» | The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. |
| Stacey Clardy, MD, PhD, FÂé¶¹´«Ã½Ó³» | Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/Âé¶¹´«Ã½Ó³» Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Âé¶¹´«Ã½Ó³» Summer Meeting CoDirector Travel and Lodging with Âé¶¹´«Ã½Ó³». Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed. |
| Bart Chwalisz, MD | Dr. Chwalisz has nothing to disclose. |
| Kristin M. Galetta, MD | Dr. Galetta has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS. |
| Akshara Balachandra, MD | The institution of Dr. Balachandra has received research support from National Institutes of Health. |
| Steven Bieser, MD | Mr. Bieser has nothing to disclose. |
| Borna Bonakdarpour, MD, FÂé¶¹´«Ã½Ó³» | Dr. Bonakdarpour has nothing to disclose. |
| Elena I. Grebenciucova, MD | Dr. Grebenciucova has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG therapeutics . Dr. Grebenciucova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen . Dr. Grebenciucova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Grebenciucova has received research support from Lupus Research Alliance . |
| Jason D. Ross, MD | Dr. Ross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston scientific , Abbott, SPR. Dr. Ross has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific . |
| Eric B. Larson, PhD | Dr. Larson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Holland & Knight. Dr. Larson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Gordon, Rees, Scully & Mansukhani. |
| Mohammad Daud Khan, MS | Mr. Khan has nothing to disclose. |
| Lutfiyya N. Muhammad, PhD | Dr. Muhammad has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Surgeons. Dr. Muhammad has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Arthritis Research & Therapy. |
| Carla M. Cuda, PhD | Dr. Cuda has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Arthritis Research & Therapy. The institution of Dr. Cuda has received research support from NIH NIAID. |
| Kathleen Aren, MPH | An immediate family member of Mrs. Aren has received personal compensation for serving as an employee of Salvation Army. |
| Asma Qureshi, MPH | Miss Qureshi has nothing to disclose. |
| Laura Arneson, MD | Dr. Arneson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Werewolf Therapeutics. |
| Deborah Winter, PhD | Dr. Winter has nothing to disclose. |
| Zachary Orban | Mr. Orban has nothing to disclose. |
| Yvonne C. Lee, MD | Dr. Lee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tonix Pharmaceuticals. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Rheumatology. Dr. Lee has or had stock in GE Healthcare.Dr. Lee has or had stock in CVS Health. The institution of Dr. Lee has received research support from NIH/NIAMS. The institution of Dr. Lee has received research support from Rheumatology Research Foundation. |
| Irene Blanco, MD | Dr. Blanco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fate Therapeutics. Dr. Blanco has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Blanco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas Biopharma. Dr. Blanco has received research support from Cabaletta. Dr. Blanco has received research support from Novartis. |
| Mary Carns, MS | Ms. Carns has nothing to disclose. |
| Tyler Therron, MS | Mr. Therron has nothing to disclose. |
| Thales H. Hein da Rosa, MSc | Mr. Hein da Rosa has nothing to disclose. |
| Vanessa Manada De Lobos | Mrs. Manada De Lobos has nothing to disclose. |
| Komel Safdar, MBBS | Dr. Safdar has nothing to disclose. |
| Anh H. Chung, BS | Ms. Chung has nothing to disclose. |
| Emily A. Breach | Ms. Breach has received research support from Rheumatology Research Fund. |
| Rosalind Ramsey-Goldman, MD, DrPH | Dr. Ramsey-Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Biogen. Dr. Ramsey-Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adicet. Dr. Ramsey-Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autolus. Dr. Ramsey-Goldman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Lupus Therapeutics. Dr. Ramsey-Goldman has received research support from NIH-to Northwestern University for my effort on the grant. Dr. Ramsey-Goldman has received research support from NIH-paid to Northwestern University for my effort ont he grant. Dr. Ramsey-Goldman has received personal compensation in the range of $10,000-$49,999 for serving as a consultant on grants with American College of Rheumatology-paid to Northwestern University for effort on grant. Dr. Ramsey-Goldman has received personal compensation in the range of $0-$499 for serving as a grant reviewer with Lupus Foundation of American. |
| Jing Song | Mrs. Song has nothing to disclose. |
| John Seagrist | Mr. Seagrist has nothing to disclose. |
| Cecilia Stumpf | Ms. Stumpf has or had stock in Gilead Sciences.Ms. Stumpf has or had stock in Novo nordisk. |
| Mary Mahieu, MD | Dr. Mahieu has or had stock in Abbvie.Dr. Mahieu has or had stock in Abbott Laboratories.Dr. Mahieu has or had stock in Baxter International.Dr. Mahieu has or had stock in Johnson & Johnson.Dr. Mahieu has or had stock in Kimberly Clark.Dr. Mahieu has or had stock in Pfizer.Dr. Mahieu has or had stock in Takeda Pharmaceutical. |
| Harris Perlman, PhD | Dr. Perlman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Arthritis Research and Therapy. |
| Katherine R. Puev | Ms. Puev has nothing to disclose. |
| Mariam Siddiqui, MD | Ms. Siddiqui has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Ms. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. |
| Neil Pillai, MS | Mr. Pillai has nothing to disclose. |